PMID: 26320497Sep 1, 2015Paper

Low Expression of the bcl2 Gene in Gastric Adenocarcinomas in Mazandaran Province of Iran

Asian Pacific Journal of Cancer Prevention : APJCP
Seyedeh Habibeh MirmajidiMohammad Shaterpour

Abstract

Gastric cancer accounts for about 8% of the total cancer cases and 10% of total cancer deaths worldwide. It is the second lethal cancer after esophageal cancer and is considered the fourth most common cancer in north and northwest Iran. The bcl2 family has a key role in the regulation of apoptosis and change in its expression can contribute to cancer. This study initially scheduled to determine the expression of bcl2 gene in tissue samples of adenocarcinoma cancer patients. A total of 10 samples of gastric adenocarcinoma and 10 of normal tissues from Sari hospital were selected and after DNA extraction from tissues, bcl2 gene expression assayed by real-time PCR. Our results demonstrated higher expression of the bcl2 gene in control compared with cancer and marginal cancer tissues. On one hand BCL2 plays an important role as an oncogene to inhibit apoptosis; on the other hand, it can initiate cell cycle arrest at G0 stage. Our observed association between its expression and patient survival is quite conflicting and may be tissue-specific. The data suggest expression both tumoural and non-tumoral(marginal) groups have lowered expression than controls (P>0.05). Due to the low number of samples we could not examine the relationship...Continue Reading

References

May 1, 1995·British Journal of Cancer·G FontaniniG Bevilacqua
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R SilvestriniB Salvadori
May 12, 1998·Surgical Oncology·R J BoldD J McConkey
Oct 17, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D M ParkinS S Devesa
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Apr 13, 2005·Oncogene·Yong Gu ChoWon Sang Park
Jun 10, 2006·Cell Death and Differentiation·S ZinkelE Yang
Sep 26, 2006·Best Practice & Research. Clinical Gastroenterology·Anthony Axon
May 31, 2008·BMC Cancer·Grace M CallagyCarlos Caldas
Feb 7, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G F LehnerdtH S Bachmann
Jun 23, 2009·The Journal of Urology·Hiroshi HirataRajvir Dahiya
Aug 7, 2009·Human Genetics·Anya N MilneG J A Offerhaus
Feb 18, 2010·Molecular Cell·Jerry E ChipukDouglas R Green
Jul 19, 2011·Developmental Cell·Jean-Claude Martinou, Richard J Youle
Sep 3, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Leila RostamizadehEbrahim Sakhinia

❮ Previous
Next ❯

Citations

Nov 13, 2020·Clinical and Experimental Gastroenterology·Khadijeh Kalan FarmanfarmaHamid Salehiniya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

© 2021 Meta ULC. All rights reserved